Benefit-Risk And Medical Costs of Rivaroxaban 15mg Versus Vitamin K Antagonists From A French Nationwide Cohort of 220,000 Patients With Non-Valvular Atrial Fibrillation
Abstract
Authors
P Blin L Fauchier J Dallongeville C Dureau-Pournin M Bernard R Lassalle C Droz-Perroteau F Sacher N Moore